Residency · Tampa, FL
Sponsored by AdventHealth Florida
Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 486 citations · Hye Chon
NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 349 citations · Hye Chon
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 323 citations · Hye Chon
A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 148 citations · Hye Chon, Robert Wenham
Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 85 citations · Hye Chon
NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2025.
Journal of the National Comprehensive Cancer Network : JNCCN · 2025 · 55 citations · Hye Chon
Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 42 citations · Hye Chon
NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021.
Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 134 citations · Hye Chon